In our previous study, we found high expression of ANGPTL4 in PC9/GR cells [18], suggesting that ANGPTL4 may be one of the potential targets for gefitinib resistance in lung adenocarcinoma cells. The gene discussed is ANGPTL4; the disease is lung adenocarcinoma.